An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.


Updates from The Motley Fool

Latest updates on EXACT Sciences from Fool.com.


Stock Performance

EXAS vs. S&P 500 | 2 Year Performance
View Interactive EXAS Charts
Sponsored by

Key Data Points

Primary metrics and data points about EXACT Sciences.
Current Price: $19.51
Prev Close: $19.19
Open: $19.23
Bid: $19.50
Ask: $19.51
Day's Range: $19.17 - $19.78
52wk Range: $4.67 - $22.80
Volume: 1,247,501
Avg Vol 5,272,142
Market Cap: $1.88B
P/E (ttm): -10.54
EPS (ttm): -$1.82
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about EXACT Sciences.
CAPS Rating 2 out of 5
 
224 Outperform
39 Underperform
CAPS All Stars
 
37 Outperform
14 Underperform

How do you think EXACT Sciences will perform against the market?



You pick for EXACT Sciences is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kevin T. Conroy, CEO

78% Approve

Based on 18 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for EXACT Sciences.

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers